NR 565 - advanced pharmacology FINAL - Chamberlain Practice
EXAM Chamberlain University-Illinois | UPDATED Questions with
100% Verified Answers
Question:
In which patient population is Metformin contraindicated in?
A. Diabetics with HA1c < 7.0%
B. Patients older than 50
C. Alcoholics
D. Women suffering from infertility
Answer:
C. Alcoholics
Question:
What lab value suggests metformin might be contraindicated?
A. eGFR <30
B. Crea 0.8
C. WBC 7.8
D. Bun 17
Answer:
A. eGFR <30
Question:
What medication is contraindicated to treat diabetes if a
patient already has a cardiac ejection fraction rate of 40%?
A. Second Generation sulfonyureas
B. Thiazolidinediones
C. Dopamine Agonist
D. Glucosidase Inhibitor
Answer:
B. Thiazolidinediones
Question:
Sabrina is a 35-year-old female who presents with complaints
,of fatigue, anxiety, and palpitations. She has a long history of
obesity and reports that she is happy that she has lost 23
pounds in the last 2 months. She also reports that she has
trouble sleeping and her husband complains that she is
keeping the house too cold. Physical exam reveals slight
tachycardia at 104 bpm and a slightly enlarged thyroid.
Thyroid testing reveals hyperthyroidism or Grave's disease.
Which of the following agents is the first-line treatment for
hyperthyroidism or Grave's disease?
A. Methimazole
B. Metoprolol
C. Allopurinol
D. Levothyroxine
Answer:
A. Methimazole
Question:
Which of the following medications would be considered the
first line of treatment for a newly diagnosed Diabetic patient
with adequate renal and hepatic function? A: NovoLog
Sliding Scale Insulin B: Liraglutide (Victoza) C: Oral
Metformin D: Glipizide
Answer:
C: Oral Metformin
Question:
Of the following medications, which is most likely to cause
hypoglycemia?
A. Metformin
B. Insulin
C. Incretin mimetics
D. Thiazolidinediones
, Answer:
B. Insulin
Question:
Which symptoms are most expected of a patient diagnosed
with hypothyroidism?
A. shortness of breath, wheezing, fatigue
B. tachycardia, insomnia, weight loss, goiter
C. irritability, anxiety, dizziness, increased sweating
D. dry pale skin, brittle hair, fatigue, myxedema
Answer:
D. dry skin, brittle hair, fatigue, myxedema
Question:
Patients with an increased risk for UTIs and genital infections
or an active diagnosis, should avoid what drug class/es for
treatment of Type II Diabetes?
A. Thiazolidinediones (Glitazones)
B. Biguanide.
C. Sodium-Glucose Cotransporter 2 (SGLT-2) Inhibitors.
D. All of the above.
Answer:
C. Sodium-Glucose Cotransporter 2 (SGLT-2) Inhibitors.
Question:
A 45-year-old patient with a history of type 2 diabetes
presents to the clinic for a follow-up appointment. The
healthcare provider has prescribed metformin as part of the
treatment plan. Which of the following statements regarding
metformin is correct?
A. Metformin primarily stimulates insulin production from
the pancreas.
, B. Metformin reduces glucose levels primarily by decreasing
insulin resistance.
C. Metformin is associated with a risk of hypoglycemia.
D. Metformin improves insulin sensitivity and reduces hepatic
glucose production.
Answer:
D. Metformin improves insulin sensitivity and reduces hepatic
glucose production.
Question:
In what part of the body are SGLT-2 (sodium-glucose
cotransporter 2) inhibitors active?
A. Small intestine
B. Pancreas
C. Renal tubules
D. Stomach
Answer:
C. Renal tubules
Question:
Which of the following statements is not true regarding
sulfonylureas?
A. Sulonlyreas are safe to prescribe to pregnant and/or
breast-feeding women.
B. Patients should be educated about signs and symptoms of
hypoglycemia.
C. Sulfonylureas cause a dose-dependent reduction in blood
glucose.
D. Sulfonylureas are indicated for only patients diagnosed
with type 2 diabetes.
Answer:
A. Sulonlyreas are safe to prescribe to pregnant and/or
breast-feeding women.
EXAM Chamberlain University-Illinois | UPDATED Questions with
100% Verified Answers
Question:
In which patient population is Metformin contraindicated in?
A. Diabetics with HA1c < 7.0%
B. Patients older than 50
C. Alcoholics
D. Women suffering from infertility
Answer:
C. Alcoholics
Question:
What lab value suggests metformin might be contraindicated?
A. eGFR <30
B. Crea 0.8
C. WBC 7.8
D. Bun 17
Answer:
A. eGFR <30
Question:
What medication is contraindicated to treat diabetes if a
patient already has a cardiac ejection fraction rate of 40%?
A. Second Generation sulfonyureas
B. Thiazolidinediones
C. Dopamine Agonist
D. Glucosidase Inhibitor
Answer:
B. Thiazolidinediones
Question:
Sabrina is a 35-year-old female who presents with complaints
,of fatigue, anxiety, and palpitations. She has a long history of
obesity and reports that she is happy that she has lost 23
pounds in the last 2 months. She also reports that she has
trouble sleeping and her husband complains that she is
keeping the house too cold. Physical exam reveals slight
tachycardia at 104 bpm and a slightly enlarged thyroid.
Thyroid testing reveals hyperthyroidism or Grave's disease.
Which of the following agents is the first-line treatment for
hyperthyroidism or Grave's disease?
A. Methimazole
B. Metoprolol
C. Allopurinol
D. Levothyroxine
Answer:
A. Methimazole
Question:
Which of the following medications would be considered the
first line of treatment for a newly diagnosed Diabetic patient
with adequate renal and hepatic function? A: NovoLog
Sliding Scale Insulin B: Liraglutide (Victoza) C: Oral
Metformin D: Glipizide
Answer:
C: Oral Metformin
Question:
Of the following medications, which is most likely to cause
hypoglycemia?
A. Metformin
B. Insulin
C. Incretin mimetics
D. Thiazolidinediones
, Answer:
B. Insulin
Question:
Which symptoms are most expected of a patient diagnosed
with hypothyroidism?
A. shortness of breath, wheezing, fatigue
B. tachycardia, insomnia, weight loss, goiter
C. irritability, anxiety, dizziness, increased sweating
D. dry pale skin, brittle hair, fatigue, myxedema
Answer:
D. dry skin, brittle hair, fatigue, myxedema
Question:
Patients with an increased risk for UTIs and genital infections
or an active diagnosis, should avoid what drug class/es for
treatment of Type II Diabetes?
A. Thiazolidinediones (Glitazones)
B. Biguanide.
C. Sodium-Glucose Cotransporter 2 (SGLT-2) Inhibitors.
D. All of the above.
Answer:
C. Sodium-Glucose Cotransporter 2 (SGLT-2) Inhibitors.
Question:
A 45-year-old patient with a history of type 2 diabetes
presents to the clinic for a follow-up appointment. The
healthcare provider has prescribed metformin as part of the
treatment plan. Which of the following statements regarding
metformin is correct?
A. Metformin primarily stimulates insulin production from
the pancreas.
, B. Metformin reduces glucose levels primarily by decreasing
insulin resistance.
C. Metformin is associated with a risk of hypoglycemia.
D. Metformin improves insulin sensitivity and reduces hepatic
glucose production.
Answer:
D. Metformin improves insulin sensitivity and reduces hepatic
glucose production.
Question:
In what part of the body are SGLT-2 (sodium-glucose
cotransporter 2) inhibitors active?
A. Small intestine
B. Pancreas
C. Renal tubules
D. Stomach
Answer:
C. Renal tubules
Question:
Which of the following statements is not true regarding
sulfonylureas?
A. Sulonlyreas are safe to prescribe to pregnant and/or
breast-feeding women.
B. Patients should be educated about signs and symptoms of
hypoglycemia.
C. Sulfonylureas cause a dose-dependent reduction in blood
glucose.
D. Sulfonylureas are indicated for only patients diagnosed
with type 2 diabetes.
Answer:
A. Sulonlyreas are safe to prescribe to pregnant and/or
breast-feeding women.
